Fanconi Anemia Repair Pathway Dysfunction, a Potential Therapeutic Target in Lung Cancer
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Fanconi Anemia Repair Pathway Dysfunction, a Potential Therapeutic Target in Lung Cancer
Authors
Keywords
-
Journal
Frontiers in Oncology
Volume 4, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2014-12-19
DOI
10.3389/fonc.2014.00368
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Mutations in ERCC4, Encoding the DNA-Repair Endonuclease XPF, Cause Fanconi Anemia
- (2013) Massimo Bogliolo et al. AMERICAN JOURNAL OF HUMAN GENETICS
- Cancer statistics, 2013
- (2013) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Stereospecific PARP Trapping by BMN 673 and Comparison with Olaparib and Rucaparib
- (2013) J. Murai et al. MOLECULAR CANCER THERAPEUTICS
- ERCC1 Isoform Expression and DNA Repair in Non–Small-Cell Lung Cancer
- (2013) Luc Friboulet et al. NEW ENGLAND JOURNAL OF MEDICINE
- Trapping of PARP1 and PARP2 by Clinical PARP Inhibitors
- (2012) J. Murai et al. CANCER RESEARCH
- Phase II Study of Single-Agent Navitoclax (ABT-263) and Biomarker Correlates in Patients with Relapsed Small Cell Lung Cancer
- (2012) C. M. Rudin et al. CLINICAL CANCER RESEARCH
- Assessment of FANCD2 nuclear foci formation in paraffin-embedded tumors: a potential patient-enrichment strategy for treatment with DNA interstrand crosslinking agents
- (2012) Wenrui Duan et al. Translational Research
- SLX4, a coordinator of structure-specific endonucleases, is mutated in a new Fanconi anemia subtype
- (2011) Chantal Stoepker et al. NATURE GENETICS
- Mutations of the SLX4 gene in Fanconi anemia
- (2011) Yonghwan Kim et al. NATURE GENETICS
- RAD51C: a novel cancer susceptibility gene is linked to Fanconi anemia and breast cancer
- (2010) K. Somyajit et al. CARCINOGENESIS
- Mutation of the RAD51C gene in a Fanconi anemia–like disorder
- (2010) Fiona Vaz et al. NATURE GENETICS
- 53BP1 loss rescues BRCA1 deficiency and is associated with triple-negative and BRCA-mutated breast cancers
- (2010) Peter Bouwman et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Targeting homologous recombination repair defects in cancer
- (2010) Bastiaan Evers et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Principles of Cancer Therapy: Oncogene and Non-oncogene Addiction
- (2009) Ji Luo et al. CELL
- MicroRNA-34a is an important component of PRIMA-1-induced apoptotic network in human lung cancer cells
- (2009) Wenrui Duan et al. INTERNATIONAL JOURNAL OF CANCER
- Functional Interaction between the Fanconi Anemia D2 Protein and Proliferating Cell Nuclear Antigen (PCNA) via a Conserved Putative PCNA Interaction Motif
- (2009) Niall G. Howlett et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- CHK1 inhibition as a strategy for targeting fanconi anemia (FA) DNA repair pathway deficient tumors
- (2009) Clark C Chen et al. Molecular Cancer
- Inhibition of Poly(ADP-Ribose) Polymerase in Tumors fromBRCAMutation Carriers
- (2009) Peter C. Fong et al. NEW ENGLAND JOURNAL OF MEDICINE
- ABT-263: A Potent and Orally Bioavailable Bcl-2 Family Inhibitor
- (2008) C. Tse et al. CANCER RESEARCH
- Promoter Hypermethylation of the PALB2 Susceptibility Gene in Inherited and Sporadic Breast and Ovarian Cancer
- (2008) A. Potapova et al. CANCER RESEARCH
- Secondary BRCA1 Mutations in BRCA1-Mutated Ovarian Carcinomas with Platinum Resistance
- (2008) E. M. Swisher et al. CANCER RESEARCH
- Activity of the Bcl-2 Family Inhibitor ABT-263 in a Panel of Small Cell Lung Cancer Xenograft Models
- (2008) A. R. Shoemaker et al. CLINICAL CANCER RESEARCH
- Evolutionary plasticity of genetic interaction networks
- (2008) Julia Tischler et al. NATURE GENETICS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started